Dextroamphetamine Treatment for ADHD

Age-Specific Treatment Recommendations

The American Academy of Pediatrics recommends behavioral therapy as first-line treatment for 4-5 year olds, with stimulants like dextroamphetamine reserved for cases where behavioral interventions fail and moderate-to-severe functional impairment persists 1
FDA-approved stimulant medications are strongly recommended as first-line treatment for elementary school children, with or without behavioral therapy (preferably both) 1
The American Academy of Child and Adolescent Psychiatry recommends FDA-approved medications with adolescent assent for adolescents, with behavioral therapy as an optional adjunct 1
Adults should start with 5 mg of dextroamphetamine, titrating upward in 5-10 mg intervals weekly until symptom control, with maximum daily doses typically reaching 40 mg 2

A systematic 4-week trial with weekly dose escalations is recommended for dextroamphetamine: 2.5, 5, 7.5, and 10 mg, with ADHD rating scales obtained from parents/teachers at each dose level 2
Monitoring for side effects, including blood pressure, pulse, height, and weight, should be done at baseline and key intervals 2
Weekly contact during initial titration is recommended to assess response and tolerability, with systematic questioning about specific stimulant side effects 3

Approximately 70% of children respond to either dextroamphetamine or methylphenidate alone, and nearly 90% respond if both are tried, according to the Journal of the American Academy of Child and Adolescent Psychiatry 2
The evidence quality for stimulants is particularly strong, superior to non-stimulants like atomoxetine, extended-release guanfacine, and extended-release clonidine, as stated by the American Academy of Pediatrics 1

Dexedrine Spansules are available, and the dose can be determined by adding morning and noon immediate-release doses together, as recommended by the Journal of the American Academy of Child and Adolescent Psychiatry 2
Combining short-acting with sustained-release formulations can increase efficacy, duration, and dosing flexibility 2

Non-stimulant medications (atomoxetine, extended-release guanfacine, extended-release clonidine) should be considered as first-line when substance abuse history exists, as recommended by the Praxis Medical Insights 4
If stimulants are necessary despite substance abuse history, close monitoring is recommended 4
Severe or primary depression should be treated first before addressing ADHD, and for comorbid anxiety, non-stimulants may be preferred initially as stimulants can exacerbate anxiety 4